Matt Cunning

Matt Cunning has made 11 investments in companies such as: PolyTherics, Destiny Pharma, BioCeramic Therapeutics, Ambicare Health, Calon Cardio-Technology, RepRegen, Sky Medical Technology, Biotronics3D, CyDen, Domainex, MessageBird.

Location of Matt Cunning is Calgary, Canada.

The free version of Angel Match provides limited data for Matt Cunning. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.

Matt Cunning is a Vice President and he his investment types are: Private Equity Firm.
Matt Cunning focuses investing in industries such as: Cloud Computing, Enterprise Software, Messaging, Telecommunications, Biotechnology, Health Care, Medical, Neuroscience, Content Discovery, Product Research, Biopharma, Manufacturing, Medical Device, Therapeutics, Health Diagnostics.

A short brief about investor:


Past investments

  • PolyTherics
  • Destiny Pharma
  • BioCeramic Therapeutics
  • Ambicare Health
  • Calon Cardio-Technology
  • RepRegen
  • Sky Medical Technology
  • Biotronics3D
  • CyDen
  • Domainex
  • MessageBird

Social media:

Available after registration.